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ABSTRACT

FUNCTIONAL CHARACTERIZATION OF MITOGEN-DEPENDENT AND SELF
PERPETUATING NB2 LYMPHOMA CELL LINES
Charlotte A. Cockrell, Bachelor of Science Mary Washington College
A thesis submitted in partial fulfillment of the requirements for the degree of
Master of Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2000
Raphael J. Witorsch, Ph.D., Professor, Department of Physiology

This investigation involved the functional characterization of four Nb2 sub lines (Nb2-U17, Nb2-l l , SFJCD l , and D5) for their mitogenic and apoptotic responses to DEX ± PRL
treatment. Many protein factors have been implicated to be crucial in controlling the
apoptotic and mitogenic pathways. In conjunction with functional studies, an
immunocytochemical investigation of four protein signals (NFKB, I KBa, STAT 5b, and
the GR) was undertaken in an attempt to establish a relationship between the functional
responsiveness of a given cell line and the concentration of a particular protein marker.
Comparison of the functional data obtained for the four lines reveals marked differences
in behavior in response to DEX ± PRL. The Nb2-l l and U-17 sublines were dependent
upon prolactin for proliferation and were sensitive to DEX induced cytolysis/apoptosis in
the absence of PRL. Co-incubation of DEX and PRL resulted in both an inhibition of

IX

apoptosis by PRL and an inhibition of mitogenesis byDEX. On the other hand, the
SFJCDI (SF) and 05 sublines proliferated in the absence of prolactin and were resistant.
to the anti-mitogenic and cytolytic/apoptotic effects ofDEX. The differences in
functional behavior between the mitogen-dependent and -independent cell lines could not
be correlated with the expression of a particular protein marker.

CHAPTER ONE
INTRODUCTION

1.1 Background

Apoptosis is a natural process whereby a single cell or groups of cells are programmed to
commit suicide in an orderly fashion; for this reason, apoptosis is interchangeably
referred to as programmed-cell death (Donner, et al. 1999) . Apoptosis occurs during
many physiological processes such as, embryogenesis, t-cell tolerance, metamorphosis,
and adjustment of cell number including tumor cell and infected cell elimination (Lang,
et al. 1999). In addition to the beneficial and crucial physiological processes that rely on
apoptosis, there are a multitude of environmental and internal factors that result in the
stimulation of unnecessary apoptosis, which can be harmful to an organism (Lang, et al.
1999). Some of these factors include, bacterial toxins, radiation, gross increase in
extracellular osmolarity, oxidative stress, c-myc over-expression, growth factor depletion,
stimulation of certain membrane receptors (TNF and CD-95/Fas/ AP0-1 receptor),
ischemia, and glucocoticoid hormones (GCH) (Cifone, et al. 1999; Lang, et al. 1999).
Cells are programmed to die when the delicate balance between survival factors and
death factors is upset (Mann, et al. 2000). Excessive apoptosis can cause
neurodegeneration and immunodeficiency, while inadequate apoptosis may lead to tumor
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development or excessive functions such as, enhanced hormone production or
autoimmune disease (Lang, et a!. 1999).

Apoptosis is an energy-dependent process (Kerr, et a!. 1972; Wyllie, et a!. 1980; Kerr and
Searle 1980; Whitfield, et a!. 1968) that is easily recognizable and distinguishable from
necrosis by certain hallmark events. The process of apoptosis is initiated by caspase
activation, thought to be the central mediator of the apoptotic phenotype (Mann, et a!.
2000). Morphologically, apoptosis is recognizable by the appearance of cellular
shrinkage thought to be induced by the loss of intracellular potassium ions (Bortner, et a!.
1997; Bortner, et a!. 1997). In addition, nuclear condensation and translocation of
phosphatidylserine residues to the extracellular surface occurs, which aids in recognition
of the dying cell by local cells and the immune system (Mann, et al.2000; Lang, et a!.
1999). Later in the onset of apoptosis, the chromatin of the cell condenses and the DNA
is cleaved by endonucleases (Wyllie, et a!. 1980; Mann, et a!. 2000). Ultimately, the cell
is broken down into small particles called apoptotic bodies (Lang, et a!. 1999), which are
quickly engulfed by resident tissue cells and digested within a few hours by
phagolysosomes (Searle, et a!. 1982). Throughout the process of apoptotic cell break
down the cell membrane is never breached, thus avoiding intracellular protein release and
consequent inflammation (Lang, et a!. 1999).

In contrast to apoptosis, necrosis is a less organized cell death process that ultimately
results in an immune response and inflammation of the surrounding tissues (Wyllie, et a!.
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1980). Necrosis can be caused by a number of factors including physical damage,
hyperthermia, inhibition of oxidative phosphorylation, glycolysis or the citric acid cycle,
autolysis, hypoxia, complement, and a variety of toxins (Lang, et a!. 1999; Thompson
1998). Unlike apoptosis, which usually affects single cells or scattered cells, necrosis
usually affects groups of contiguous cells (Wyllie, et a!. 1980), or tracts of tissue (as in an
infarct) (Searle, et a!. 1982). Affected cells dilate, their mitochondria swell, other
organelles dissolve, the plasma membrane ruptures, the nucleus dilates, and the
chromatin disperses (Wyllie, et al. 1980; Searle, et al. 1982). When the membrane bursts
intracellular proteins leak out into the surrounding extracellular fluid, activating an
immune response, which results in inflammation and tissue damage (Lang, et al. 1999).
Specialized phagocytic cells (Wyllie, et al. 1980) eventually ingest the debris produced
from the rupture of a necrotic cell, but dead cells may persist in a histologically
recognizable form for days to weeks (Searle, et al. 1982).

The focus of our laboratory has been on glucocorticoid-induced apoptosis in the rat Nb2
lymphoma cell line. Glucocorticoids (GCs) have been proven to activate apoptosis in
thymocytes and neoplastic lymphocytes (Wyllie 1980; Cohen and Duke 1984; Bansal, et
al. 1991; Baxter, et al. 1971), including Nb2 cells (Fletcher-Chiappini, et al. 1993),
making GCs an effective treatment for lymphoid cancers (Feinman, et al. 1999). Cifone
et al. (1999) have recently proposed a pathway through which GC-induced apoptosis
occurs. The first step involved is the binding of hormone or in this case dexamethasone
(DEX), a synthetic glucocoticoid, to the glucocorticoid receptor (GR). This leads to
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phosphoinositol-phospholipase C (PI-PLC) activation, which consequently initiates
diacylglycerol (DAG) release. DAG release leads to acidic sphingomyelinase (aSMase)
activation, which cleaves ceramide thereby releasing it to activate the caspase cascade.
Activation of the caspase cascade that leads to transcription and protein synthesis and
ultimately results in apoptosis (Cifone, et al. 1999). Other investigators have proposed
that transcription is the initial event leading to the apoptosis cascade (Cohen and Duke
1984; Nicholson, et al. 1978; Helmberg, et al. 1995), however apoptosis induced by
exogenous ceramide is prevented by inhibiting mRNA and protein synthesis, suggesting
that transcription is a downstream event (Cifone, et al. 1999).

It is apparent that one or more regulatory pathways must exist to keep the deadly action
of glucocorticoids to some cell types in check. Jamieson et al.

(2000) were able to

demonstrate the existence of a regulatory crosstalk pathway between the GR and the T
cell receptor (TCR), and were able to show that the GR inhibits TCR/CD3 activation
induced death via MEK (mitogen-activated protein kinase kinase) in primary splenic T
cells (Jamieson and Yamamoto

2000).

Furthermore, other investigators have shown that

the GR inhibits TCR-induced apoptosis via repression ofFasL transcription (Yang, et
al.l995). In vivo GC levels are regulated in response to diurnal cycling and stress levels
(Jamieson and Yamamoto 2000). It is possible to speculate that this GR/TCR crosstalk
pathway may also be responsible for preventing GC-induced apoptosis of T cells
combating inflammation or infection (Jamieson and Yamamoto

2000) making it

a

reciprocal pathway. Jamieson's group of investigators also found that Ras signaling
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during TCR signal transduction in a thymoma cell line prevented GC-induced apoptosis
(Jamieson and Yamamoto 2000). This implies that the same crosstalk pathway may also
exist in thymocytes (Jamieson and Yamamoto 2000).

The Nb2 lymphoma cell line used by our laboratory is a pre-T cell (thymocyte)
suspension culture derived from the lymph node of an estrogen-treated male Noble (Nb)
rat (Noble, et a!. 1985; Gout, et a!. 1980; Fleming, et a!. 1982). Although these cells were
taken from the lymph node, they are not mature B or T lymphocytes (Fleming, et a!.
1982). The surface antigens expressed or not expressed by Nb2 cells reveal that these
cells are not B cells, mainly due to the lack of immunoglobulin expression (Fleming, et
a!. 1982). On the other hand, it is their expression of both W3/25-HLK (CD4) and OX8HL (CD8) antigens, which are expressed on different subsets of mature T cells, that
indicate that they are too immature to be defined as T cells (Fleming, et a!. 1982). In fact,
their surface antigens suggest that the Nb2 lymphoma cell line arose from a thymocyte at
some intermediate stage of development that is not clearly defined (Fleming, et a!. 1982).
The first experimental use of the Nb2 cell line was as a bioassay for lactogenic hormones
(e.g. human growth hormone and human PRL hormone) (Tanaka, et a!. 1980).

Nb2 cells

are profoundly sensitive to lactogenic hormones from a variety of species and can be used
to quantitate the concentration of a given hormone (Tanaka, et a!. 1980).

Our investigation involved the use of the following four unique Nb2 sublines: Nb2-U-17,
Nb2-11, SFJCDl, and D5. The Nb2-U-17 (wild-type) and Nb2-11 lines are critically
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dependent upon prolactin (PRL) or other lactogen (e.g. human growth hormone or
placental lactogen) for proliferation (Gout, et a!. 1980; Gout, et a!. 1994), and the
SFJCDI (SF) and D5 cultures proliferate in the absence ofPRL or other mitogen (Gout,
et a!. 1994). The lactogen-independent lines were developed by the withdrawal of
lactogenic hormone from PRL-dependent cultures, and subsequent propagation of the
surviving cells in media devoid of !actogens (Gout 1987). The autonomous nature of the
SF cell prompted an investigation into whether these cells were producing their own
PRL-like substance. Assays testing for the presence of autonomous mitogens
(endogenous lactogenic hormones) or growth factors produced by these cells were
negative (Witorsch, et a!. 1993; Gout 1987).

Our laboratory has investigated the functional behavior of bothPRL-dependent and
independentNb2 lines in response to DEX

± PRL

treatment. We have observed the

following: I) DEX initiates apoptosis in a concentration dependent manner via the GR in
thePRL-dependentNb2clone 2line (Fletcher-Chiappini, et a!. 1993), 2) At very low
concentrations ( l ng/mL) PRL effectively inhibits DEX-induced apoptosis inPRL
dependentNb2lines (Fletcher-Chiappini, et a!. 1993), 3) IOOnM DEX is anti-mitogenic
to thePRL-independent SFJCD I (SF) (Witorsch, Day, et a!. 1993), and 4) Extracellular
Ca2+ is not required forPRL or DEX action (LaVoie and Witorsch 1995).

In addition to

the anti-apoptotic action ofPRL, a reciprocal effect could be demonstrated whereby DEX
was able to preventPRL-induced mitogenesis ofNb2 cells (Fletcher-Chiappini, et a!.

1993). Due to the divergent nature of the signal transduction pathways leading to
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mitogenesis and apoptosis, it has been suggested that the opposite inhibitory actions
caused by DEX on mitogenesis and PRL on apoptosis involve a complex interplay
between the post-receptor mechanisms of the PRL and glucocoticoid receptors (Fletcher
Chiappini, et a!. 1993).

The immunocytochemical (ICC) approach has been employed by our laboratory to study
the signaling associated with apoptosis control in Nb2 lymphoma cells. Using ICC we
have demonstrated the existence of the following protein markers in Nb2 cells: NFKB,
IKBa., STAT Sb, GR, Bcl-2, Bax, Fas, FasL, and p53 (Gaunzon 1998; Badarinath 1999).
With the exception of p53, the specificity of immunostaining the preceding antibodies
has been validated by immunoabsorption (Gaunzon 1998; Bardarinath 1999).
Preliminary studies were unable to establish the existence of a dynamic relationship
between the level of expression of a given signal before and after DEX treatment
(Gaunzon 1998; Badarinath 1999).

More recently our laboratory has focused on the following four protein markers: NFKb,
lKBa., STAT Sb, and GR. The first marker mentioned, NFKB or nuclear factor kappa B,
is the most frequently occurring heterodimeric complex (p65/p50) of the NFKB family
found in the cell. However, there are actually five proteins in the NFKB family including,
NFKB 1 (pSO/p 100), NFKb2 (p522/p 100), Re!A (p65), e-Re! and Re!B (De Bosscher, et
a!. 2000). In the inactivated state, NFKB is bound to an inhibitor, IKBa., in the cytoplasm
of the cell (HeUmann, et a!. 1999). Upon activation NFKB is released from IKBa. and
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NFKB dimers translocate to the nucleus where they bind to variousKb DNA binding
sites and regulate the transcription of certain genes (Hettmann, et a!. 1999). NFKB can
promote apoptosis or cell survival depending upon the cell type and context (F einman, et
a!. 1999). However, most studies indicate that the Rel/NFKB family of transcription
factors play an important role in the protection of cells from apoptosis either by
constitutive expression ofNFKB or by its induction (Sonenshein 1997). In a study
performed by Ivanov and Nikolic-Zugic (1998) on double positive thymocytes (as are
Nb2 cells), GCs were shown to induce a moderate upregulation ofRelA-p50 (NFKB)
relatively late in the apoptosis cascade after caspase-dependent degradation of several
nuclear proteins.

This up-regulation ofNFKB was associated with the activation of the

proteosome and the consequent degradation ofiKBa (Ivanov andNikolic-Zugic 1998).
In addition, it has been shown by another group of investigators that afterNFKB has
translocated to the nucleus, the GR interferes with the transactivating domain of the p65
subunit thereby repressing transcription of p65 mediated gene products (D e Bosscher, et
a!. 2000). Therefore, althoughNFKb is upregulated by glucocorticoids late during the
apoptosis cascade, subsequent downregulation in the nucleus ultimately results in a
repression ofKB gene transcription and the protective effects of the gene products. This
evidence is supported by the findings of Sen and Sen. who found that following the
injection of mice with GCs there was a drop inNFKB DNA-binding activity in immature
CD 8+/CD4+ lymphocytes preceding apoptosis (Sonenshein 1997). These investigations
suggest a possible crucial role forNFKb in determining cell survival.
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IKBa or inhibitor kappa B alpha, mentioned briefly above, is bound to inactivatedNFKB
in the cytoplasm of the cell (Hettmann, et al. 1999), functioning as an inhibitor by
sequesteringNFKB in the cytoplasm. IKBa contains six copies of a structural motif
called an ankryrin repeat, which is necessary for the interaction withNFKB (Whiteside
and Israel 1997). Ankyrin repeats sequesterNFKB in the cytoplasm by masking the
nuclear localization sequence situated in the C-terminal region of the Rei homology
domain (Beg, et al.I992; Ganchi, et al. 1992). Additional structural attributes include an
N terminal pair of serine residues and a C-terminal region rich in proline, glutamate,
aspartate, serine and threonine residues (PEST domain) implicated in regulating the
stability ofiKBa, as well as playing a role in the ability ofiKba to inhibit DNA-binding
by Rel/NFKB complexes (Whiteside and Israel 1997). When the cell is activated by any
number of apoptotic stimuli, IKBa is phosphorylated and subsequently degraded resulting
in the release ofNFKB (Hettmann, et al. 1999). Upon release from IKBa, NFKB dimers
translocate to the nucleus where they bind to various KB promoter sites and regulate the
transcription of genes that have protective effects on the cell (Hettmann, et al. 1999;
Sonenshein 1997). After degradation ofiKBa it is then resynthesized in anNFKB
dependent manner (Whiteside and Israel 1997). In the case of glucocorticoid treatment,
the induced synthesis ofiKBa byNFKB leads to translocation ofiKBa to the nucleus
where it can inhibitNFKB by binding to its target sites (Arenzana-Seisdedos, et al. 1995).
Furthermore, translocation ofNFKB to the nucleus is inhibited by mutating IKBa to a
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super-repressor form (Wang, et a!. 1996). Translocation to the nucleus can also be
prevented by mutations to the serine-specific kinases that phosphorylate IKba. or to the
proteosome responsible for degradation of IKBa. (Whiteside and Israel 1997; Brown, et
a!. 1995). These investigations suggest that the integrity and concentration of the IKBa.
protein play a critical role in determining cell survival, and that IKBa. is a mobile protein
capable of inhibiting NFKB in both the cytoplasm and the nucleus.

Signal Transducer and Activator of Transcription 5B or STAT 5B may also play a role in
controlling apoptosis. The JAK/STAT pathway is activated as a result of PRL binding to
the PRL receptor and it is implicated in transducing the mitogenic signal to the nucleus of
the cell (Rui, et a!. I 998). JAKs are constitutively associated with the cytoplasmic
domain of cytokine receptors (Starr, et a!. 1999). Binding of ligand to its receptor
induces dimerization of the receptor chains, bringing together two JAK kinases that are
activated by transphosphorylation (Starr, et a!. 1999). In the case of PRL binding, J ak2 is
activated. Jak2 in tum phosphorylates STAT SA, 5B, 1, and 3 in addition to the serine
kinases ERK 1 and 2 (Starr, et a!. 1999; Rui, et a!. 1998). Upon activation STATs
dimerize and migrate to the nucleus where they activate the transcription of genes that
mediate the cytokine-induced biological response (Starr, et a!. 1999). It may be
postulated then that over-expression of STATs, particularly STAT 5B, in Nb2 cells may
afford protection from apoptosis. In support of this hypothesis it has been documented
that STAT 5 represses the GC response (Pfiztner, et a!. 1998). Therefore, an over-
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expressed STAT 5B protein inNb2 lymphoma cells may afford protection fromGC
induced apoptosis.

A fourth protein that may play a role in producing either glucocorticoid resistance or
sensitivity is theGR itself. It has been postulated that mutation or downregulation of the
GR may be the cause of glucocorticoid hormone insensitivity. In 1988 Rosewicz et al.
(1988) found that downregulation of theGR could be found for up to 72 hours afterGC
treatment (Rosewicz, et al. 1988). However, they also found that the synthetic
glucocoticoid dexamethasone (DEX) had no effect on the level ofGR expressed, and
studies performed by Oldenburg et al. in 1997 support this evidence. In addition,
Oldenburg and his group found that DEX-insensitive thymocytes possessed fully
functionalGRs, and they found that the molecular weight and abundance of the receptor
does not change after DEX treament, indicating that theGR is neither downregulated nor
mutated (Oldenburg, et al. 1997), which is consistent with earlier findings in our
laboratory (Witorsch, et al. 1993). Oldenburg's findings suggest that theGR is not
responsible for the apoptosis-resistant phenotype, and that there must be other factors that
confer apoptosis resistance or sensitivity.

The over- or under-expression of one or more of these proteins could have an obvious
effect on apoptosis regulation. The initial studies byGuanzon (1998) and Badarinath
(1999) failed to demonstrate any acute changes between a given signal and DEX
treatment. More recently we have attempted to correlate the functionality ofNb2 cells
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with the level of expression of these markers. 26 sublines were generated from a single
Nb2-11 cell using a limiting dilution technique. Some of these sublines demonstrated
distinct levels of sensitivity to DEX-induced cytolysis/apoptosis as measured by trypan
blue exclusion and TdT-mediated dUTP-biotin nick end labeling (TUNEL) (Patel 1999;
Rebano 1999).

In addition, the degree of sensitivity of a given subline to DEX treatment

was statistically correlated to the percentage of cells immunostained for NFKB, IKBa.,
STAT 5b, and the GR (Patel 1999; Rebano 1999). This suggested that all of the markers
were localized within a single population of cells, which was confirmed by co
localization of the four markers discussed using a modification of Immunocytochemistry
methodology (Rebano 1999).

1.2

Objective

To date, immunocytochemistry methodology has provided little insight into the
mechanisms involved in control of apoptosis and mitogenesis in Nb2 lymphoma cells.
Through the use ofiCC we have been unable to observe changes in the expression of
signals associated with physiologic manipulation of cells (e.g. treatment with DEX or
removal of mitogen) (Gaunzon 1998; Badarinath 1999). The limiting dilution approach
whereby sublines were generated for the characterization of signaling in apoptosis control
was found to be of limited value for two main reasons. First, the generation of the
sublines through limiting dilution is not a quantitative process because there is no way to
confirm that a given cell line arises from only one cell. Therefore, the homogeneity of a
given subline is assumed. Second, the functional variation between sublines was narrow
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making differences difficult to correlate statistically. On the other hand, the results of
this approach suggested that a correlation did exist between functional behavior and the
existence of certain markers.

Our current strategy was to determine if differences in signal expression as measured by
ICC could be detected in sublines of Nb2 cells that exhibit marked functional differences.
The Nb2- l l and U-17 (wild-type) lines are dependent upon PRL for mitogenesis, and it
has been documented that the former undergoes apoptosis in response to nanomolar
concentrations of DEX (Fletcher-Chiappini 1993). In contrast, the SFJCDl (SF) and D5
lines are PRL-independent with regard to mitogenesis and the former has been shown to
be resistant to DEX-induced apoptosis. If the signals of interest are involved in the
apoptosis pathway, than differences in their level of expression may be demonstrable by
ICC.

The purpose of this thesis was to functionally characterize the hormonal control of
mitogenesis and apoptosis in the SF, D5, Nb2- l l , and U-17 cell lines. Functionality was
examined by determining the cytolytic/apoptotic and mitogenic responses to DEX ± PRL
treatment. ICC was used to determine if we could detect differences in immunostaining
of the four signals of primary interest (NFKB, lKBa, STAT 5b, and GR) in the four cell
lines.
In addition to the four lines described above, we have generated two additional
phenotypic variants in our laboratory. One line (named LTI for long-term culture) was
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generated by the prolonged incubation ofNb2-l l cells with subculturing (dilutions of
I :9 or I: 19 every two to three days) for an extended period of time (one year or more).

This resulted in a phenotype that was less sensitive to DEX-induced cytolysis and had the
capacity to self-proliferate. A second subline (named PI for prolactin-independent) was
generated by subculturing theNb2-l l in media devoid of mitogen (fetal bovine serum).
The PI cells appeared to be mitogen-independent and also had a decreased sensitivity to
DEX-induced cytolysis (Gannon 2000, unpublished results).

CHAPTER TWO

MATERIALS AND METHODS

2.1 Maintenance of Nb2 Lymphoma Cells

Four Nb2 lymphoma cell lines were obtained from Dr. Peter Gout of the Cancer Control
Agency in Vancouver, British Columbia in February of 2000. Mitogen dependent cell
lines (Nb2-U-17 and Nb2-l l ) were maintained in Fischer's Maintenance Medium
(FMM), containing chemically defined Fischer's Medium (Sigma), 50U/mL penicillin,
50!-lg/mL streptomycin, O. l mM�-mercaptoethanol, 0.075% sodium bicarbonate, 10%
horse serum (HS) and I 0% fetal calf serum (FCS). Mitogen independent cell lines
(SFJCDI and D5) were maintained in Fisher's Stationary Medium (FSM), which is
equivalent to FMM with the exception that it contains no FCS. Fischer's Medium and�
mercaptoethanol were purchased from the Sigma Chemical Company, and all other
media components were purchased from Gibco BRLI Life Technologies, Inc.

All cell lines were cultured in ventilated polystyrene 9ulture flasks in a humidified
incubator that was maintained at 37°C and 5% C02/95% room air. Cell culture
concentration and viability were determined by a cell count using a hemacytometer and
Trypan Blue (Gibco BRL, Life Technologies, and Inc.) exclusion (0.1mL cells+ 0.9mL
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trypan blue). Cell subculturing and assays were performed in a sterile environment and
6
cell cultures were not diluted to less than 0.05 X I 0 cells/mL when subcultured.

2.2 Freezing and Resurrecting Cells
Cells were routinely frozen every couple of weeks for later resurrection as needed. First,
an aliquot of cells was centrifuged at I 000 rpm for five minutes. The cells were washed
one time with FM, which involved resuspension in FM, centrifugation at I 000 rpm for
five minutes, and aspiration of the supernatant. After the wash step, the cells were
resuspended in I mL of freezing medium, transferred to 2 mL biofreeze vials (Coming
Costar Corp.), and finally stored at -70°C. The freezing medium composition differed
according to whether the cell line was mitogen-dependent or -independent. For mitogen
dependent sublines (U-17 and Nb2- ll) the freezing medium consisted of FMM/8%
DMSO (Sigma). The freezing solution for mitogen independent sublines (SFJCDI and
D5) consisted of FSM/8% DMSO.

Cells to be resurrected were first thawed and the contents of the biofreeze vial were
placed in a centrifuge tube of warmed pre-gassed (5% C02) FMM or FSM depending
upon the cell line. The cells were then placed in a humidified, 37°C incubator for ten
minutes with the cap loosened to allow the DMSO to escape from the cells. The cells
were then centrifuged at I 000 rpm for five minutes, washed with FM and resuspended in
warmed, pre-gassed FMM or FSM. Cell viability and concentration were determined by
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Trypan Blue exclusion. The cells were cultured for at least a week post-resurrection
before using them for experiments.

2.3 Cell Fixation and Spotting

The procedure for fixing and spotting cells was identical for all cell cycle phases and/or
cell treatments. First, an aliquot of cells was fixed with an equal volume of fixative
(0.01M PBS/7.4% formaldehyde prepared by diluting stock formaldehyde,37% solution,
obtained from J.T. Baker Chemicals with 0.01M PBS at 7.0 pH) at room temperature and
allowed to stand for ten minutes. The fixed cells were then centrifuged for five minutes
at 1000 rpm. The supernatant was removed and the cells were resuspended in enough
6
0.01M PBS to give a cell concentration of3.0-3.5 X 10 cells/mL. Approximately 20).lL
of fixed cells were spotted into etched circles of approximately 5mm in diameter on
Fischer Superfrost/Plus slides. The spotted slides were then covered and allowed to dry
at room temperature overnight before use in experiments.

2.4 Cytolytic Assay

The cytolytic assay is a four well assay used to test the cells responsiveness to DEX ±
ovine prolactin (oPRL). An aliquot of cells were centrifuged at 1000 rpm for five
minutes, washed once with FM and finally resuspended in chemically defined serum-free
synthetic medium (SYN). SYN consists of 0.1mM �-mercaptoethanol, 50U/mL
penicillin, 50).lg/mL streptomycin 0.15% (wt/vol.), bovine serum albumin (0.15%), 4
).lg/mL linoleic acid, I mM sodium pyruvate, 12).lg/mL transferrin, 15ng/mL selenium, 1X
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vitamins (diluted from 100X stock), 0.33X amino acids (diluted from stock 100X),
0.5mM CaCiz and hepes dissolved in FM. The cells were then counted in triplicate using
a hemacytometer and Trypan Blue exclusion, and diluted with SYN to obtain a
6
concentration of 0.56 X 10 cells/mL.

Four wells were set up on a 24 well plate as follows: I) 2.5 J..ll DMSO, 0.1mL SYN and
0.9 mL cells (control), 2) 1.25 J..l L DMSO, 1.25 J..lL DEX, 0.1 mL SYN and 0.9mL cells
(DEX), 3) 1.25 J..lL DMSO, 1.25 J..lL DEX, 0.1 mL oPRL (DEX + PRL), and 0.9 mL cells,
4) 2.5 J..lL DMSO, 0.1mL oPRL and 0.9mL cells (PRL). The assay was incubated at 37°C
and 5% C02 for 24 hours. After incubation each well was counted in triplicate using a
hemacytometer and Trypan Blue exclusion to determine the cell viability (percent living
and dead) and concentration (number of cells/mL).

2.5

Mitogenic Assay

The objective of the mitogenic assay was to determine the proliferation of a given cell
line when exposed to oPRL ± DEX over a 72-hour period. Prior to cell treatment the
cells were "cooled down" or arrested in G1 phase of the cell cycle by incubating the cells
for 24 hours in FSM/1% FCS (Buckley, et a!., 1996; Gilks, et a!., 1995). This was done
by first centrifuging an aliquot of cells at 1000 rpm for five minutes, washing two times
with FM and finally resuspending in FSM/1%FCS. The cells were then counted one time
using Trypan Blue exclusion to determine concentration and viability, and diluted to 0.50
6
X 10 cells/mL. The diluted cells were incubated in a humidified, 37°C and 5.0% C02
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incubator for 24 hours.

The same protocol was followed for the mitogen -independent

cell lines with the exception that they were resuspended and diluted with FSM.
However, these cells were not expected to "cool down" because they are mitogen
independent, but they were subjected to the same procedure to maintain experimental
consistency.

After incubating the cells for 24 hours an aliquot of the "cooled down" cells was
removed, centrifuged, washed two times with FM and resuspended in SYN. The cells
were then counted in triplicate using a hemacytometer and Trypan Blue exclusion, and
6
diluted to a concentration of 0.11 X 10 with SYN.

The four well set up for the assay was identical to that described for the cytolytic assay
above. The cells were then incubated for 72 hours in a humidified, 37°C and 5.0% C02
incubator. At end of the incubation period each well was counted in triplicate using a
hemacytometer and Trypan Blue exclusion.

2.6 Immunocytochemistry (ICC) and Immunoabsorption

Immunocytochemical assays were performed to test for the presence and abundance of
'

four protein antigens presumably associated with hormonal control of apoptosis and
mitogenesis. Working stock solutions of each polyclonal rabbit lgG antibody were
prepared from concentrated antibody solutions obtained from Santa Cruz Biotechnology.
Anti-GR (P-20) and anti-NFKB p65 (C-20) were diluted from a concentration 200 jlg/ml
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to a working concentration of 4j.lg/ml with O.OIM PBS/0.1% BSA, and anti-IKBa (C-21)
and anti-STAT 5B (C-17) were diluted from IOOj.lg/mL to 2j.lg/mL with PBS/BSA
(Sigma).

ICCs were performed using the Vectastain kit obtained from Vector Laboratories, which
contained blocking serum, secondary biotinylated antibody and tertiary ABC antibody.
Solutions in the Vectastain kit were prepared according to the kit instructions, and further
modifications as described below. After each treatment, the slides were incubated in a
humidified chamber at room temperature. Between each treatment the slides were
washed with !OmL of O.OIM PBS and immersed in a Coplin jar containing O.OIM PBS to
maintain hydration.

First, slides that had been spotted with the four Nb2 sublines (in log phase) were hydrated
for ten minutes in O.OIM PBS. Cytopore (Trevigen) was then added to each spot to
permeabilize the cells, and the slides were incubated for thirty minutes. Second, blocking
serum was added from the Vectastain kit to minimize non-specific staining, and the slides
were incubated for twenty minutes. Next, the primary working antibody solutions
(working stock solutions prepared above) were added to the spotted cells and a negative
control slide was treated with 0.0IM PBS/0.1% BSA (Sigma). The slides were then
incubated for three hours. Next, a secondary biotinylated antibody (Vectastain) was
added at a dil�ted concentration (diluted I :7 with 0.0IM PBS) to each spot, and
incubated for thirty minutes. Subsequently, tertiary ABC antibody was added after being
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diluted 1:4with 0.01M PBS, and incubated for thirty minutes. The slides were then
placed in a coplin jar for eight minutes containing 12.5 mg Diaminobenzidine (Aldrich),
50mL TRIS-HCI at 7.6 pH and 50f.LL of3.0% hydrogen peroxide, and subsequently
immersed in and washed with tap water. The slides were then run through a dehydration
series in the following order: dH20, 50% ethanol (EtOH), 70% EtOH, 95% EtOH, 100%
EtOH, I 00% EtOH and a series of four xylenes. Lastly, the slides were coverslipped
using Pro-Texx mounting medium (Scientific Products).

Immunocytochemical assays were used to test for the presence and abundance of four
protein markers: glucocorticoid receptor (GR), nuclear factor kappa B (NFKB), Signal
Tranducer and Activator of Transcription 5B (STAT 5B) and Inhibitor KB<X (IKBa).
Polyclonal rabbit IgG antibodies (Santa Cruz Biotechnology) directed against these four
protein antigens were generated in a rabbit against a 17-21 amino acid length peptide
corresponding to the amino or carboxyl terminus. Prior to performing
immunocytochemical assays, we validated antibody specificity by immunoabsorption.
To test for antibody specificity, working stock solutions of anti-NFKB p65 (4 flg/mL),
anti-IKB<X (2f.lg/mL), anti-STAT 5B (2f.lg/ml) and anti-GR (4f.Lg/mL) were incubated
with their respective peptide antigens for 24hours at 4°C at a ratio of I: 10 (antibody to
antigen on a mass basis), as recommended by the supplier. After the incubation period,
the absorbed antibody solution along with a negative control solution consisting of
PBS/0.02% BSA and of the respective working stock antibody were run through an ICC
using slides spotted with log phase Nb2 cells. We were able to confirm the specificity of
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the antibody through the absence of staining in cells treated with the absorbed antibody
solutions.

2.7 TDT-Mediated dUTP-Biotin Nick End-Labeling (TUNEL) Method

The TUNEL method was used as a qualitative confirmation of DEX-induced apoptosis.
Fischer Superfrost/Plus slides spotted with cells from the DMSO (control) and DEX
treated wells of cytolytic assays were used for TUNEL assays. An apoptosis detection kit
obtained from Trevigen was used for all TUNEL assays, and the following solutions were
used from the kit: IOX TdT Labeling Buffer, IOX Stop Buffer, Tdt dNTP, Tdt , SOX
2
Co +, Strepavidin Horseradish Peroxidase (Strep-HRP) and Diaminobenzidine (DAB)
staining solution. After each treatment and subsequent incubation, the slides were
washed with at least 10m! ofO.OIM PBS.

First, the slides were hydrated in 0.0 I M PBS for ten minutes.

Next, the cells were

permeabilized using the detergent Cytopore (Trevigen) for thirty minutes. The slides
were then subjected to five minutes of peroxidase quenching in a coplin jar at room
temperature. The peroxidase solution consisted of3.3ml30% H202 and 47.7mL ddH20
to give a solution of 2% H202.

IX labeling buffer was then applied to each circle to

equilibrate the cells to the buffer solution. Then the buffer was removed with filter paper
and 18)-lL of labeling mix was applied to each spot.

The labeling mix was prepared as

2
follows: I )lL Tdt, I )lL Tdt dNTP, I )lL Co + and 50)-lL of IX labeling buffer prepared for
every two spots. After applying the labeling mix, slides were placed in a petri dish lined
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with moist filter paper. The petri dish containing the slide was then placed in a 37°C,
humidified incubator with an atmosphere composed of 5% C02/95% room air for one
hour. After one hour the slides were placed in a IX Stop Buffer solution (5mL lOX Stop
Buffer+ 45ml ddH20) for five minutes. Next, the slides were treated with Strep-HRP
and allowed to incubate for ten minutes at room temperature. The slides were then
placed in a DAB staining solution for ten minutes and thereafter washed with tap water in
a coplin jar. Lastly, the slides were run through a dehydration series in the following
sequence dH20, 50% ethanol (EtOH), 70% EtOH, 95% EtOH, 100% EtOH, I 00% EtOH
and four xylenes, and coverslipped using Pro-Texx mounting medium.

2.8 Statistical Analysis

The SigmaStat 2.0 computer program for Windows was used to statistically analyze raw
data from mitogenic and cytolytic assays. Raw data obtained from cell counts was
entered into a spreadsheet, subjected to normality and equal variance tests, and one-way
analysis of variance (ANOVA) (a minimum of three individual assays (n=3) run at
different times were used for statistical analysis). For the data with a p<0.05 a Tukey test
was run, which involves a multiple pairwise comparison of the generated means. The
means calculated from each treatment and each cell line were then used to create graphs
using SigmaPlot 2000. The error bars on the graphs (Figures 2-5) represent the standard
error of the mean (SEM) for a given treatment.
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2.9 Photomicrography

Photomicrographs were taken of the TUNEL and ICC assays using a Nikon Polaroid
camera with a landpack attachment mounted on a Nikon Optiphot microscope. Color
polaroid type 669 film was used at SOX magnification. A representative field of cells was
photographed from each spot on each slide. The photographs were then developed and
scanned into the Corel Photo-Paint 8.0 computer program.

CHAPTER THREE
RESULTS

3.1 Nb2 Lymphoma Cell Morphology

Figure

I

represents Nb2 cells stained with Wright's Geimsa stain and illustrates the

differences between the four Nb2 lines studied. Distinct morphological differences are
clearly evident between the PRL-dependent and PRL-independent Nb2 lines. The SF and
D5 cell lines appear to be larger and more dynamic. They also have numerous
cytoplasmic projections, which are not seen as frequently in the PRL-dependent lines.
The wild-type (U-17) and Nb2- l l lines display a smaller, more rounded appearance and
they lack the dynamic appearance of the PRL-independent lines. Even though there are
discrete differences in morphology between the PRL-dependent and -independent lines,
all four cell lines display the high nucleus to cytoplasm ratio typical of neoplastic
lymphoma cells (Fleming, et a!., 1982).

3.2 Synchronized Nb2 Cell Responsiveness to 72-Hour PRL ± DEX Treatment
(Mitogenic Assay)

Figure 2 shows the mitogenic responses of the Nb2-11 and U-17 sublines after
synchronization in G l phase, plating at 1 X 105 cells/mL in SYN, and incubation for 72
hours under the following conditions: no hormone (control), PRL (lng/mL), DEX
25
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(100nM), andPRL ( l ng/mL) ± DEX (IOOnM).

In the absence ofPRL and DEX, there

was little or no increase in cell number above the plating concentration. There was a
significant increase in cell number for both lines after treatment withPRL illustrating the
dependence of these sublines uponPRL for mitogenesis. The magnitude of the response
toPRL was much greater for the Nb2-11 line, which showed a 13-fold increase in cell
number compared to a 4.3-fold increase for the U-17 line. Co-incubation ofPRL + DEX
resulted in a significant inhibition of mitogenesis in both sublines.

Figure 3 illustrates the mitogenic assay results for the SF and D5 lines.

Both sublines

exhibited pronounced hormone-independent proliferation after 72 hours with the SF cell
concentration increasing almost 19-fold and D5 cells increasing by almost 16-fold above
the plating concentration. Incubation withPRL resulted in no further significant increase
in cell concentration of either cell line. Incubation with DEX produced no significant
effect in either cell line in the presence or absence ofPRL. However, it is noteworthy to
mention that the number of SF cells incubated with DEX in the absence ofPRL was
about half that of the SF cells in the control group.

3.3 Log Phase Nb2 Cell Responsiveness to 24-Hour Treatment with DEX ± PRL
(Cytolytic Assay)

Figure 4 illustrates similar cytolytic effects of DEX ±PRL for the U-17 and Nb2-11
lines. Both lines showed an increase in the percentage of cell death after being subjected
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to a 24-hour treatment with DEX (I OOnM). The U-17 subline exhibited a 2.3-fold
increase in the percentage of dead cells after DEX treatment, whereas the Nb2- l l subline
exhibited a 3.6-fold increase in the percentage of dead cells under the same conditions.
Co-incubation of DEX with l ng/mL PRL blocked DEX-induced cytolysis/apoptosis both
cell lines.

Figure 5 shows the functional responses of the SF and D5 lines after a 24-hour treatment
with DEX ± PRL. The SF and D5 lines exhibited no significant change in cell death
percentages in response to DEX, indicating that the cells are resistant to DEX-induced
cytolysis/apoptosis. Co-incubation of DEX with I ng/mL PRL had no significant effects.

The cytolytic data collected for the D5 subline was split into two subsets ("D5" and
"Resurrected D5") and analyzed separately. The D5 cells were split into two subsets due
to the appearance of different functional behavior between batches of cells that had been
cultured for more than two weeks called "D5" and those cultured less than two weeks
post-resurrection from -70°C called "resurrected D5". Although statistical analysis
revealed no significant differences in the treatments for the "resurrected D5" cells, these
cells appeared to be functionally different from those 'perpetuated for over two weeks
("D5"). The resurrected cells have a much higher basal cell death percentage than the
latter, and they appear to have some sensitivity to DEX-induced cytolysis, as indicated by
a 23.9 %increase in cell death percentage from the control death percentage. In addition,
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the PRL appears to inhibit the cytolytic effects ofDEX in the newly resurrected cells, as
indicated by death percentages comparable to the control.

3.4 TUNEL Method Performed on Control (DMSO) and 24- Hour DEX Treated
Cells

Figure 6 is a photomicrograph of the representative TUNEL staining observed in the
control andDEX treatments of cytolytic assays for the Nb2-11 and U-17 cell lines. In
both cell lines, DEX exposure increases TUNEL labeling confirming thatDEX-induced
cytolysis reflects apoptosis, which is consistent with previous reports from this laboratory
(Fletcher-Chiappini, et al., 1993; LaVoie and Witorsch 1995; Gaunzon 1998; Patel 1999;
Rebano 1999). In contrast to that observed for the Nb2-11 and U-17, DEX failed to
increase TUNEL labeling in the SF andDS lines (Figure 7) consistent with the cytolytic
assay results.

3.5 Immuncytochemical Assays Performed on Log Phase Nb2 Cells

Figures 8 through 12 are photomicrographs taken of the representative staining produced
for the control (vehicle 0.1% BSA) and each marker (NFKB, IKBa, STAT Sb, and GR) in
all four cell lines. These figures indicate no striking differences in location or intensity of
staining between any of the markers among the four lines.
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SF

D5

U-17

Nb2-11

FIGURE I. Wright's Geimsa stain applied to log phase Nb2 cells. Morphological differences between
PRL-dt:pendent (Nb2-11 and U-17) and -independent (05 and SF) sublines are illustrated
above (80X).
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FIGURE 2. Effect ofDEX +/- PRL on concentration ofNb2-11 and U-17 cells.
- Both cell 1ines show significant increase (p<0.05, n=5) in cell
concentration after 72-hour PRL (lng/mL) treatment. PRL-induced
mitogenesis was prevented by co-incubation withDEX (1 OOnM).

31

co

0

2

0

SF

..

-

Control

05

(DMSO)

PRL

.. DEX+ PRL
CJ DEX

FIGURE 3. Effect DEX +/- PRL on concentration of SF (n=5) and D5 (n=4) cells.
No significant differences (p>0.05) were found between any of the
treatments. However, 72-hour DEX treatment appears to inhibit
mitogenesis in the SF line.
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FIGURE 4. Effect of DEX +/- PRL on viability ofNb2-l l and U-17 cells.
Both cell lines show significant increase (p<0.05, n=5) in cytolysis
after 24-hour DEX (I OOnM) treatment. DEX-induced cytolysis
is inhibited by co-incubation ofpRL (l ng/mL) with l OOnM DEX.
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FIGURE 5. Effect of DEX +I- PRL on concentration of SF (n=5), D5 (n=4), and
resurrected D5 (n=3) cells. No significant increases (p>0.05) were
found for any of the cell groups. However, D5 resurrected group
appeared to respond to 24-hour DEX treatment, and appeared to exhibit
inhibition of cytolysis when co-incubated with PRL and DEX.
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FIGURE 6. Both sublines show increased labeling of cells after 24-hour DEX exposure
consistent with DEX-induced apoptosis as measured by trypan blue
exclusion (80X).
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FIGURE 7. TUNEL method applied to cells exposed to 24-hour DMSO (control) and DEX
treatments. Both sublines show little evidence of staining consistent with
cytolytic assay results as measured by trypan blue exclusion (80X).
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FIGURE 8. Negative immunocytochemical control treatments of log phase Nb2 cells illustrate
an absence of staining when cells are treated with 0.1% BSA instead of primary
antibody (SOX).
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FIGURE 9. Immunocytochemical staining for NFkappaB using a rabbit polyclonal IgG anitbody
at 4uglmL. The pictures illustrate comparable patterns of staining in all four cell
sub lines (80X).
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FIGURE 10. Immunocytochemical staining for the GR using a rabbit polyclonallgG antibody at
4uglmL. The photomicrographs illustrate comparable staining patterns for the GR
'
in all. four sublines (SOX).
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FIGURE 11. lmmunocytochemical staining for IkappaBalpha using a rabbit polyclonal lgG

antibody at 2ug!mL. The photomicrographs illustrate comparable staining for
lkappaBalpha in all four sublines(80X).
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FIGURE 12. Immunocytochemical staining'for STAT5B using a rabbit polyclonal IgG
antibody at 2ug/mL. The photomicrographs illustrate comparable staining patterns
for STAT5B in aU four sublines (SOX).

CHAPTER FOUR
DISCUSSION

As stated earlier, this investigation had several objectives consistent with our overall goal
of gaining insight concerning the signaling involved in hormonal control of mitogenesis
and apoptosis ofNb2 lymphoma cells. First, we wanted to functionally characterize the
hormonal control of mitogenesis and apoptosis using fourNb2 lymphoma cell sublines as
models (U-17, Nb2- l l , SFJCDI, and D5). Secondly, we hoped to determine whether any
differences in expression were demonstrable by ICC ofNFKB, IKBa, STAT 5B, and GR.

This study confirmed and extended previous observations regarding the functionality of
these Nb2 sublines. There were two basic functional phenotypes exemplified by their
mitogenic response, PRL-dependent (Nb2-11 andU-17) andPRL-independent (SF JCD1
and D5). Furthermore, the former were DEX andPRL sensitive, exhibiting a
cytolytic/apoptotic response to DEX in the absence ofPRL, an inhibition of DEX
induced cytolysis/apoptosis in response toPRL treatment, and an anti-proliferative
response when DEX is co-incubated withPRL. These data are entirely consistent with
previous studies inNb2-11-related sublines ( Fletcher-Chiappini, et al., 1993; LaVoie and
Witorsch 1995; Gaunzon 1998; Patel 1999; Rebano 1999). To the best of our knowledge
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the data onDEX responsiveness and anti-apoptotic effects ofPRL for the U-17 subline
have not been previously reported.

I n contrast t o the U-17 and Nb2- l l , the SF (SFJCDl) andD5 sublines proliferated
robustly in the absence ofPRL and in our hands, appeared to bePRL-insensitive.
Previously, Gout et al. documented that the SF subline exhibited a slight sensitivity to
PRL and theD5 was more sensitive than the SF (Gout 1987; Gout, et al., 1994; Gout, et
al., 1997) . The reason for the discrepancy between Gout's findings and those in our
laboratory is unknown. Perhaps the differences are methodological or are due to the
adaptive nature of cancer cells themselves. Minute differences may exist between
different batches of cells that are as of yet undocumented. In contrast toPRL-dependent
cells, the SF andD5 sublines exhibitedDEX-resistance. No significantDEX-induced
anti-proliferation was observed nor was there any indication ofDEX-induced
cytolysis/apoptosis in either line. PRL-independent proliferation is well established for
these two lines (Witorsch, et al., 1993; Gout 1987; Gout, et al. 1994; Gout, et al., 1997);
however, the lack of DEX sensitivity exhibited by the SF is inconsistent with a previous
report from this laboratory. Witorsch et al. (1993) reported thatDEX significantly
inhibitedPRL-independent mitogenesis of SF cells. It is noteworthy, however, that while
no statistically significant effect ofDEX on SF cell proliferation was demonstrable, the
mean number of cells found in SF cells exposed toDEX for 72 hours was about 50% of
the control. The lack of statistical significance under these conditions could reflect a
"false negative" or type II or beta error resulting from an imprecision in the assay due to
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inadequate sample size (n=5) or high variability in the results. Alternatively, the lack of
statistical significance could indicate a change in DEX-sensitivity over time (i.e. current
batch of SF cells versus those examined previously). As shown in other work in this
laboratory (discussed below, Gannon 2000) hormone sensitivity of the Nb2 lymphoma
can change with long-term culturing of the cells.

Cytolytic assay data suggest a change occurs over a short period of time after resurrection
in the D5 subline. In our previous experience, no such changes have been observed after
resurrection in other lines. Freshly resurrected D5 cells appeared to behave like PRL
dependent cells exhibiting sensitivity to DEX-induced cytolysis and anti-apoptosis in
response to PRL treatment, in addition to high basal cell death. While it is noteworthy
that no statistical significance was observed (again reflecting a possible type II error;
n=3), this apparent difference shortly after resurrection, as compared to behavior after
two weeks of culture post-resurrection, could suggest some transformation that this
subline might undergo, or that this subline is unusually compromised by freezing or
needs time to assume its full potential after resurrection. In support of the possibility that
these cells may have undergone transformation, Buckley et a!. demonstrated that treating
the SF line with a differentiating agent (sodium butyrate) results in a transient reversion
back to PRL-dependence and a decrease in the level ofpim-1 expressed, and most
importantly, the SF line becomes sensitive to DEX-induced apoptosis (Buckley, et a!.,

1997). Buckley's work suggests that PRL-dependence and DEX sensitivity are acquired
through cell dedifferentiation, which may be what we are observing in the D5 line as
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evidenced by theirDEX responsiveness shortly after resurrection and their loss of
responsiveness after approximately two weeks.

Cancer cells are known to change their phenotype with time, which usually correlates
with malignant progression (Gout, et a!., 1994). Phenotypic changes include the loss of
growth requirements of specific hormones or growth factors, increases in growth rate,
development of drug resistance, tissue invasiveness, metastatic ability, and drug
resistance (Nowell 1986; Nicolson 1987). It has been specifically documented that
lymphoid cancers that are initially responsive to GC treatment develop a resistance to
GC's after prolonged treatment (Feinman, et a!., 1999; Klumper, et a!., 1995).

We may

be witnessing some of these phenotypic changes in theD5 line after resurrection. Gout et

al. documented the change in growth and size over a 2.3-year period of an Nb2
lymphoma line (called Nb2-PRA) after splitting the line into two independent cultures
(Gout, et a!., 1994). Initially both cultures showed a gradual decrease in doubling time.
Then one of the cultures spontaneously increased its doubling time in conjunction with
the appearance of substantially larger cells, which eventually became the predominant
cell type. In contrast, this larger cell type never developed in the other culture and the
doubling time eventually stabilized at 13 hours (Gout, et a!., 1994). Although the
changes we witnessed in theD5 line resulted inDEX resistance, the cells were not
cultured withDEX, and therefore their resistance toDEX-induced apoptosis cannot be
attributed to prolonged exposure toDEX. Perhaps like the changes in the Nb2-PRA line,
theD5 is undergoing a non-induced change in phenotype related to the progression of
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that particular type of cancer cell. This phenotypic change consequently affords theD5
line withDEX resistance. The patterns observed inD5 and resurrectedD5 (Figure 5) is
an extremely rapid occurrence (less than two weeks), suggesting that cancer cells have
the ability to change their functional behavior very rapidly.

The current investigation was paralleled by another investigation in the laboratory that
studied the effects of long-term culture on an Nb2-ll line, similar to the investigation
Gout et a!. undertook with the Nb2-PRA line. Unlike the Gout's investigation, no
obvious morphological changes were documented in the cells. However, phenotypically
an Nb2-11 subline cultured for a year or more (named LTI for long-term incubation)
became autonomous and less sensitive toDEX-induced apoptosis, suggesting that with
time the Nb2-11 is undergoing malignant progression with long-term culture. This study
also revealed a relatively rapid transformation of cells deprived of mitogen (FCS) (named
PI for prolactin-independent). In addition to a loss ofDEX sensitivity, both the LTI and
PI exhibited hormone-independent proliferation (Gannon 2000). Thus, the sublines
recently generated in our laboratory are similar functionally to the SF andD5 lines.

In contrast to the similar cytolytic assay results for the Nb2-11 and U-17 lines (Figure 4),
the mitogenic assay results showed some variation in' PRL responsiveness between the
two lines. The Nb2-11 line gave a much more robust response to PRL producing a 13fold increase in growth from baseline, while the U-17 only showed a 4.3-fold increase in
cell number (Figure 2). In fact, the Nb2-11 line has been found to have a faster growth
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rate when perpetuated in culture than the U-17 (unpublished results). Gout et a!.
documented a 14-hour doubling time for the Nb2- l l (Gout, et a!., 1994; Gout, et a!.,
1997), which is in agreement with our records. This is significantly faster than the 17-24hour doubling time for the U-17 (unpublished results), which may account for the more
robust response of the Nb2-11 to PRL.

The inhibition of cell proliferation by DEX observed in the PRL exposed Nb2-l l and U17 sublines, and possibly the autonomous SF subline in the mitogenic assay, may be due
to cell cycle control mechanisms. King and Cidlowski found that glucocorticoid
treatment of lymphoid cell lines expressing markers of immature thymocytes results in
G I arrest, and in most cases, growth inhibition is followed by cell death (King and
Cidlowski 1998). Perhaps the observed inhibition of mitogenesis is actually an arrest in
the G I phase of the cell cycle.

In addition to the previously documented phenotypic differences among the Nb2 sublines
supported by these studies, certain other functional and genotypic characteristics are
worth noting. The U-17, Nb2-l l , and SF lines all induce the growth of tumors when
implanted subcutaneously in Noble rats, but only the Nb2-11 and SF lines metastasize to
other sites in the animal (Gout, et a!., 1994). Karyotyping of these three lines has shown
the U-17 and Nb2- l l lines to be identical with both displaying five additional changes
with respect to the normal Noble rat karyotype, and the SF line has six additional changes
with respect to the U-17 karyotype (Horsman, et a!., 1991). The identical nature of the
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U-17 and Nb2- l l makes the differences in functional behavior between these two lines
all the more intriguing.

The DS line has not been studied as extensively as the U-17, Nb2-ll or SF lines. The
functional results obtained from our investigation suggest that the DS is probably closer
to the SF in karyotype than the parent line. However, karyotyping of the DS line has
revealed that this line has no greater than two additional chromosomal changes compared
to the parent line (Gout, et al., 1997). These two or fewer changes then must be
responsible for a radically different phenotype compared to the parent line. The
chromosomal and subsequent behavioral alterations associated with malignant
progression in the Nb2 line suggest that the resistance to treatment seen in the SF and DS
lines is probably attributable to many cooperative changes.

The phenotypic differences observed when comparing the U-17 and Nb2-ll to the DS
and SF may reflect differences in intracellular signaling. While numerous signals could
be implicated in self-proliferation and resistance to DEX-induced cytolysis/apoptosis this
study considered the GR, STAT SB, NFKB, and IKBa. As reviewed in the introduction,
the GR is critical to initiate DEX-induced apoptosis. STAT SB, a component of the
JAK/STAT cascade mediates PRL-induced effects. lKBa, which sequesters NFKB in the
cytoplasm of the cell, is involved in GC-mediated effects and prevents NFKB from
translocating to the nucleus (Hettman, et al., 1999; Whiteside and Israel 1997) making it
a pro-apoptotic factor. One would suspect, therefore, that a self-proliferating, DEX-
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resistant cell line might exhibit increased expression of STAT 5B and NFKB, and reduced
expression of the GR and IKBa, or a combination thereof relative to the Nb2-11 and/or U17 cells. In support of this hypothesis it has been documented that STAT 5 represses the
GC response (Pfiztner, et al., 1998), supporting the hypothesis that increased STAT 5B
could prevent GC-induced apoptosis. However, our preliminary ICC studies reveal no
striking differences in the immunostaining of the four signals of interest among the four
Nb2 sublines. These negative findings must be interpreted cautiously. As it is currently
performed, our ICC methodology may be inadequate to detect changes in the expression
of proteins. Our current method is designed to produce maximal staining intensity, and
this may be insensitive to modest changes in signal expression. Hence, we are only able
to differentiate between cells that express antigen and those that do not (Gaunzon 1998;
Badarinath 1999; Patel 1999; Rebano 1999). In other words, we might detect a change in
the proportion of cells stained under varying conditions. However, the assay will have to
be modified in order to detect changes in the levels of antigen expression (i.e. staining
intensity differences on an individual cell basis). This requires titering of the primary
antibody to the dose-response curve relating protein content to staining intensity. Such
modification in ICC methodology is currently under development in our laboratory.

In addition, changes in antigen expression may not be a function of the physiologic
phenotype, but of the physiologic status of the cells (i.e. the state of hormonal
manipulation). In the current ICC studies, assays are performed on cells in log phase
growth. The Nb2-11 and U-17 cells proliferate in response to lactogenic medium
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(medium supplemented with FCS), whereas the SF and D5 are self-proliferating sublines.
Changes in signal expression may, therefore, require such changes as removal of mitogen
or exposure to DEX prior to the ICC assay.

Alternatively, other signals may be implicated in the phenotypic differences or the
mechanisms involved may be of increased complexity. It has been previously observed
that the SF line has the ability to increase glutathione production in response to oxidative
stress (Meyer, et a!., 1998). Therefore, perhaps pretreatment with DEX ± PRL may be
required to produce noticeable changes in the concentrations ofNFKB, IKBa, STAT 5b,
and the GR. It been reported that levels of cysteine and glutathione in a human T cell
line can modulate the activity ofNFKB (Gout, et a!. 1994). L-cystine or rather its
reduced form cysteine is an essential amino acid required for mammalian lymphocytes,
and a number of malignant human and animal cell lines of lymphoid origin, which lack
the ability to synthesize the amino acid (Inglhart, et a!., 1977; Ishii, et a!., 1981 ) . The
Nb2-l l , U-17, and D5 lines must be grown in media supplemented with 2mercaptoethanol (2-ME) in order to synthesize cysteine (Gout, et a!. 1997). On the
contrary, the SF line has an enhanced cystine uptake capability affording it with 2-ME
independence (Gout, et a!. 1997). When the cells are subjected to an experiment
involving DEX ± PRL treatment, they are first removed from their respective growth
media and placed in serum-free, chemically defined media devoid of 2-ME. The SF is
unaffected by the change in media. However, theNb2-ll , U-17, and D5 may undergo
changes inNFKB concentration due to a change in media; the activity ofNFKB
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apparently depends upon optimal levels of cysteine and glutathione (Gout, et a!., 1997).
Placing the U-17, Nb2-11, and D5 cells in media devoid of 2-ME would inhibit cysteine
production, which would in tum lower NFKB levels and make the cells more susceptible
to DEX-induced apoptosis. This explanation is consistent with the functional response of
the U-17 and Nb2-11, but it is inconsistent with the DEX-insensitivity we see in the D5
line. Therefore, although cysteine levels may play a role in the sensitivity to DEX
induced apoptosis, cysteine levels alone do not dictate functional behavior.

It has been reported that DEX-insensitive thymocytes possess fully functional GRs, and
the molecular weight and abundance of the receptor does not change after DEX
treatment, indicating that the GR is neither down-regulated nor mutated (Oldenburg, et
a!., 1997). Interestingly though, treatment with non-synthetic glucocorticoids has been
reported to cause down-regulation of the GR for up to 72 hours after treatment
(Rosewicz, et a!., 1988). The reason for this discrepancy is unknown. The
immunocytochemical staining intensity and concentration of the GR was similar for all
four lines, but again, the ICC studies were performed on log phase cells. Therefore,
future studies should involve comparison of log phase versus DEX treated cells in order
to ascertain the integrity and concentration of the GR, and to confirm the studies
performed by Oldenburg.

In the SF line p21ras and mitogen activated protein kinase (MAPK) are both constitutively
active, but in hormone-dependent cultures such as the Nb2-ll , PRL is necessary to
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activate this signaling pathway in conjunction with the JAK2/STAT cascade (Buckley, et
a!., 1997). This suggests that the enhanced Ras and MAPK expression found in SF cells
may be responsible for PRL-independence and cooperative in preventing apoptosis
(Buckley, et a!., 1997).

In conclusion, our findings indicate that major differences in functional behavior exist
between the PRL-dependent and PRL-independent lines, as evidenced by cytolytic and
mitogenic assay results. These differences in behavior are probably not attributable to
any one protein signal or chromosomal change, but are most likely due to progressive
changes in phenotype that accompany malignant progression (Nowell 1986). Future
studies will involve a more focused immunocytochemical investigation of protein
markers.
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